U.S. markets closed
  • S&P 500

    3,841.47
    -11.60 (-0.30%)
     
  • Dow 30

    30,996.98
    -179.03 (-0.57%)
     
  • Nasdaq

    13,543.06
    +12.15 (+0.09%)
     
  • Russell 2000

    2,168.76
    +27.34 (+1.28%)
     
  • Crude Oil

    51.98
    -1.15 (-2.16%)
     
  • Gold

    1,855.50
    -10.40 (-0.56%)
     
  • Silver

    25.57
    -0.29 (-1.12%)
     
  • EUR/USD

    1.2174
    +0.0001 (+0.01%)
     
  • 10-Yr Bond

    1.0910
    -0.0180 (-1.62%)
     
  • GBP/USD

    1.3684
    -0.0046 (-0.34%)
     
  • USD/JPY

    103.7700
    +0.2650 (+0.26%)
     
  • BTC-USD

    32,083.74
    -574.95 (-1.76%)
     
  • CMC Crypto 200

    651.44
    +41.45 (+6.79%)
     
  • FTSE 100

    6,695.07
    -20.35 (-0.30%)
     
  • Nikkei 225

    28,631.45
    -125.41 (-0.44%)
     

SHAREHOLDER ALERT: Barr Law Group Investigating the Officers and Directors of SRPT, PS, RP, and PGZ; Shareholders are Encouraged to Contact the Firm

Barr Law Group
·2 min read

SAN DIEGO, Jan. 12, 2021 (GLOBE NEWSWIRE) -- National law firm Barr Law Group is investigating the actions of the officers and board of directors of Sarepta Therapeutics, Inc., Pluralsight, Inc., RealPage, Inc., and Principal Real Estate Income Fund. If you are a current owner of shares of any of these stocks, contact leo@barrlaw.com or call (619) 400-4966.

Sarepta Therapeutics, Inc. (NASDAQ: SRPT)

Barr Law Group is investigating Sarepta Therapeutics, Inc. regarding possible breaches of fiduciary duties and other violations of law, including securities claims on behalf of shareholders. On January 7, 2021, Sarepta revealed that its one-time gene therapy for Duchenne muscular dystrophy did not show benefits compared to a placebo. Following this news, Sarepta stock dropped roughly 49.7%, during after-market trading, and opened at $85.00 on January 8, 2021. To learn more about this investigation and your rights, visit: http://barrlaw.com/investor-contact. Representation is contingency based, no out of pocket costs.

Pluralsight, Inc. (NASDAQ: PS)

Barr Law Group is investigating Pluralsight, Inc. regarding possible breaches of fiduciary duties and other violations of law related to Pluralsight’s agreement to be acquired by Vista Equity Partners for $20.26 per share. To learn more about this investigation and your rights, visit: http://barrlaw.com/investor-contact. Representation is contingency based, no out of pocket costs.

RealPage, Inc. (NASDAQ: RP)

Barr Law Group is investigating RealPage, Inc. regarding possible breaches of fiduciary duties and other violations of law related to RealPage’s agreement to be acquired by Thoma Bravo for $88.75 in cash per share. To learn more about this investigation and your rights, visit: http://barrlaw.com/investor-contact. Representation is contingency based, no out of pocket costs.

Principal Real Estate Income Fund (NYSE: PGZ)

Barr Law Group is investigating Principal Real Estate Income Fund regarding possible breaches of fiduciary duties and other violations of law, including securities claims on behalf of shareholders. To learn more about this investigation and your rights, visit: http://barrlaw.com/investor-contact. Representation is contingency based, no out of pocket costs.

Concerned shareholders are encouraged to contact Leo Kandinov to learn more:

leo@barrlaw.com
(619) 400-4966
www.barrlaw.com

Barr Law Group is a boutique law firm consisting of highly experienced and specialized litigators who represent investors in securities litigation and corporate governance matters. The firm would be happy to further discuss these matters, and any legal rights or remedies potentially available to you, at no charge.

Attorney Advertising. Past results do not guarantee a similar outcome.

Contact:

Leo Kandinov, Partner
leo@barrlaw.com
619-400-4966
501 W Broadway Suite 800
San Diego, CA 92101
www.barrlaw.com